miR-663 has been reported to target renin (REN) and apolipoprotein E (APOE) mRNAs and a decrease in miR-663 has been associated with an increase in renin mRNA in patients with hypertension (Marques et al., 2011). Here, REN is linked to hypertensive disorder.